These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34556341)

  • 1. Erratum to "Letter to the Editor: Comment on 'Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions''' [Lung Cancer 159 (2021) 127].
    Maat APWM; Cornelissen R; Bogers AJJC; Mahtab EAF
    Lung Cancer; 2021 Nov; 161():202. PubMed ID: 34556341
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Comment on 'Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions'.
    Lung Cancer; 2021 Sep; 159():127. PubMed ID: 34332334
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions.
    Larose F; Quigley N; Lacasse Y; Martel S; Lang-Lazdunski L
    Lung Cancer; 2021 Jun; 156():151-156. PubMed ID: 33962765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.
    Nelson DB; Rice DC; Niu J; Atay SM; Vaporciyan AA; Antonoff MB; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao AS; Gomez DR; Giordano SH; Mehran RJ; Sepesi B
    Eur J Cardiothorac Surg; 2018 May; 53(5):960-966. PubMed ID: 29211849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma.
    Casiraghi M; Maisonneuve P; Brambilla D; Solli P; Galetta D; Petrella F; Piperno G; De Marinis F; Spaggiari L
    Eur J Cardiothorac Surg; 2017 Nov; 52(5):975-981. PubMed ID: 28482086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review.
    Kapeles M; Gensheimer MF; Mart DA; Sottero TL; Kusano AS; Truong A; Farjah F; Laramore GE; Stelzer KJ; Patel SA
    Am J Clin Oncol; 2018 Jan; 41(1):30-35. PubMed ID: 26353120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality management of malignant pleural mesothelioma.
    Sugarbaker DJ; Norberto JJ
    Chest; 1998 Jan; 113(1 Suppl):61S-65S. PubMed ID: 9438692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapies in malignant pleural mesothelioma.
    Cinausero M; Rihawi K; Cortiula F; Follador A; Fasola G; Ardizzoni A
    Crit Rev Oncol Hematol; 2019 Dec; 144():102815. PubMed ID: 31670225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of radiotherapy to surgery and chemotherapy improves survival in localized malignant pleural mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) study.
    Thompson AB; Quinn TJ; Siddiqui ZA; Almahariq MF; Grills IS; Stevens CW
    Lung Cancer; 2020 Aug; 146():120-126. PubMed ID: 32531717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
    Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
    J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.
    Nelson DB; Rice DC; Niu J; Atay S; Vaporciyan AA; Antonoff M; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao A; Gomez D; Giordano SH; Mehran R; Sepesi B
    J Clin Oncol; 2017 Oct; 35(29):3354-3362. PubMed ID: 28817374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic coronary surgery in a case of malignant mesothelioma previously managed with trimodality treatment.
    Dhurandhar V; Robinson BM; McCaughan BC; Bulliard C; Bannon PG
    Heart Lung Circ; 2014 Oct; 23(10):e198-201. PubMed ID: 24996387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of failure after trimodality therapy for malignant pleural mesothelioma.
    Baldini EH; Recht A; Strauss GM; DeCamp MM; Swanson SJ; Liptay MJ; Mentzer SJ; Sugarbaker DJ
    Ann Thorac Surg; 1997 Feb; 63(2):334-8. PubMed ID: 9033296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The timing of chemotherapy in the management plan for medically operable early-stage malignant pleural mesothelioma.
    Shohdy K; Abdel-Rahman O
    Expert Rev Respir Med; 2019 Jun; 13(6):579-584. PubMed ID: 30977408
    [No Abstract]   [Full Text] [Related]  

  • 15. Trimodality management of malignant pleural mesothelioma.
    Maggi G; Casadio C; Cianci R; Rena O; Ruffini E
    Eur J Cardiothorac Surg; 2001 Mar; 19(3):346-50. PubMed ID: 11251277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
    Nelson DB; Rice DC; Mitchell KG; Tsao AS; Gomez DR; Sepesi B; Mehran RJ
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):924-929. PubMed ID: 31430846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma.
    Okubo K; Sonobe M; Fujinaga T; Shoji T; Sakai H; Miyahara R; Bando T; Date H; Shibuya K; Hiraoka M
    Gen Thorac Cardiovasc Surg; 2009 Nov; 57(11):585-90. PubMed ID: 19908112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to Letter to Editor from Fodor et al., "The 'Radical' Palliation That Increases Survival in Malignant Pleural Mesothelioma".
    Gomez DR; Rimner A
    J Thorac Oncol; 2019 Dec; 14(12):e284-e285. PubMed ID: 31757385
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.
    Bölükbas S; Manegold C; Eberlein M; Bergmann T; Fisseler-Eckhoff A; Schirren J
    Lung Cancer; 2011 Jan; 71(1):75-81. PubMed ID: 19765853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-year prospective results of trimodality treatment for malignant pleural mesothelioma.
    Pagan V; Ceron L; Paccagnella A; Pizzi G
    J Cardiovasc Surg (Torino); 2006 Oct; 47(5):595-601. PubMed ID: 17033611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.